Stay Connected

  • This field is for validation purposes and should be left unchanged.

Together, We Create Real Impact

3 Legislative wins in 2012 Over 30M Raised 5 FDA treatments approved

From the Blog

  • February 23, 2017

    National Brain Tumor Society Statement on Tocagen Designation

    Today, Tocagen, a company developing a gene therapy to treat cancer, announced that it has received “Breakthrough Therapy Designation*” for its lead product candidate Toca 511 & Toca FC** from the U.S. Food and Drug Administration (FDA) for the treatment of recurrent high-grade glioma (glioblastomas and anaplastic astrocytomas). Tocagen was granted Breakthrough Therapy Designation based [

    Read More

  • February 23, 2017

    this is… not the end. A brain tumor documentary concludes, celebrating life

    joshnjennalove

    “Life is fragile,” Jennifer Keenan Giliberto said. The Georgia photographer’s work shows the complex fragility and strength of the human spirit. She’s also a brain tumor survivor. In May of 2015, I cove

    Read More

  • February 16, 2017

    From the CEO’s Desk: The Future of National Healthcare Policy

    From_the_CEOs_Desk_565x274

    National Brain Tumor Society’s mission is to find better treatments, and ultimately a cure, for all brain tumors. And our interim ‘Big Hairy Audacious Goal’ is to help turn a brain tumor diagnosis

    Read More

More from the blog
Share